MRI-guided Neurosurgical Ablation Market Worth $5.6 Billion by 2026: Grand View Research, Inc.

SAN FRANCISCO, Aug. 7, 2019 /PRNewswire/ -- The global MRI-guided neurosurgical ablation market size is expected to reach USD 5.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.5% over the forecast period. Increasing incidence of brain tumors & other nervous system disorders and increasing adoption of minimally invasive neurosurgeries are some of the factors anticipated to boost growth.

Key suggestions from the report:

    --  Accessories segment dominated the market in 2018. This can be attributed
        to increasing number of patients suffering from brain tumors, followed
        by benign tumors.
    --  Hospitals segment dominated the market in 2018 with highest share owing
        to high prevalence of malignant tumors in central nervous system and
        increase in geriatric population.
    --  North America dominated the mri-guided neurosurgical ablation market
        with highest revenue share in 2018 owing to increase in awareness about
        minimally invasive neurosurgeries and availability of skilled
    --  Some of the key players are launching technologically advanced products
        and signing partnership agreements to gain competitive advantage in the
        industry. For instance, in January 2018, INSIGHTEC signed an agreement
        with VirginiaTech Carilion Research Institute (VTCRI) for developing
        MRI-guided noninvasive treatments.

Read 165 page research report with TOC on "MRI-guided Neurosurgical Ablation Market Size, Share, & Trends Analysis Report By Product (Radiofrequency Ablation Systems, Laser Ablation Systems), By End Use (Hospitals, Clinics, Ambulatory Surgical Centers), And Segment Forecasts, 2019 - 2026" at:

Increasing number of patients suffering from brain tumor is one of the factors expected to drive growth. Brain tumors can also spread to other sites in the brain (secondary or metastatic). Each type of cancer has its own treatment, biology, and prognosis. Similarly, brain cancer also has certain risk factors, which occurs due to abnormal growth of cells. According to the National Institutes of Health (NIH), in 2016, 1,65,813 people were living with brain cancer in the U.S. and in 2019, it is estimated that 17,760 people are expected to die due to brain cancer.

Technological advancements are also expected to aid market growth. For instance, Medtronic developed a Visualase MRI-guided laser ablation device that monitors tissue ablation in real time. It has the smallest laser catheter with a diameter of 1.65 mm, which results in a smaller incision, helping patients recover faster. It uses laser technology to destroy unwanted soft tissues. Hence, rising number of minimally invasive procedures is expected to aid growth.

Grand View Research has segmented the MRI-guided neurosurgical ablation market on the basis of product, end use, and region:

    --  MRI-guided Neurosurgical Ablation Product Outlook (Revenue, USD Million,
        2015 - 2026)
        --  MRI-guided Radiofrequency Ablation Systems
        --  MRI-guided laser Ablation Systems
        --  MRI-guided Focused Ultrasound Systems
        --  Accessories
    --  MRI-guided Neurosurgical Ablation End-use Outlook (Revenue, USD Million,
        2015 - 2026)
        --  Hospitals
        --  Clinics
        --  Ambulatory Surgical Centers
    --  MRI-guided Neurosurgical Ablation Regional Outlook (Revenue, USD
        Million, 2015 - 2026)
        --  North America
            --  U.S.
            --  Canada
        --  Europe
            --  Germany
            --  U.K.
            --  Italy
            --  France
            --  Spain
            --  Russia
        --  Asia Pacific
            --  China
            --  India
            --  Japan
            --  Australia
            --  South Korea
            --  Singapore
        --  Latin America
            --  Mexico
            --  Brazil
            --  Argentina
            --  Colombia
        --  Middle East & Africa
            --  Saudi Arabia
            --  South Africa
            --  UAE

Find more research reports onMedical Devices Industry, by Grand View Research:

    --  Blood Clot Retrieval Devices Market - A person suffers by a stroke when
        insufficient blood flow results in cell death. Strokes are of two types,
        ischemic and hemorrhagic. Ischemic is due to lack of blood flow and
        hemorrhagic is due to internal bleeding.
    --  Fetal Monitoring Analysis Market - Increasing prevalence of cardio
        pulmonary diseases, technological advancement such as non invasive
        surgeries, increasing government and non-government initiatives for
        maternal & fetal health over the world.
    --  Blood Glucose Monitoring Devices Market - The global blood glucose
        monitoring devices market is anticipated to grow at a significant rate
        in the forecast period owing to rising prevalence of diabetes and
        increase in adoption of continuous sugar surveillance systems.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Follow Us: LinkedIn | Twitter

View original content:

SOURCE Grand View Research, Inc.